AbbVie Retires Cholesterol Drugs Amid Risk-Benefit Doubts
AbbVie Inc. on Friday said that it would stop selling several of its cholesterol medications, including Advicor and Simcor, in the U.S. following a request from the U.S. Food and Drug...To view the full article, register now.
Already a subscriber? Click here to view full article